Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine.
Authors:
- 1 January 1991
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 88 (1) , 199-203
Abstract
Production of live attenuated oral poliomyelitis vaccine (OPV) requires rigorous neurovirulence safety testing of each vaccine lot, currently carried out in monkeys. It has been reported that a change from 472-U to 472-C in the type 3 OPV RNA is associated with an increased histologic lesion score produced upon intraspinal inoculation of the mutant virus in monkeys. We have developed a method, based on polymerase chain reaction, for measuring the relative abundance of these mutant sequences directly in vaccine preparations and used this method to evaluate the proportion of 472-C in 40 different lots of type 3 OPV. Six vaccine lots that had failed the intraspinal monkey neurovirulence test contained a higher proportion of 472-C than all other lots that had passed this test. OPV type 3 virus containing 472-C was rapidly selected during serial passages in African green monkey kidney cells that are used for manufacturing of the vaccine. We have also found that the wild-type poliovirus type 3 strain Leon/37, from which the vaccine strain was originally derived, contained a mixture of 472-U and 472-C sequences. No other mutations in OPV type 3 RNA have been detected by similar assays at position 2034, also associated with attenuation, or at several other positions reported to be altered in some vaccine preparations. Our results suggest that molecular diagnostics may provide a supplement or a potential alternative to animal testing of live attenuated vaccines.Keywords
This publication has 11 references indexed in Scilit:
- Translation deficiency of the sabin type 3 poliovirus genome: Association with an attenuating mutation C472 → UVirology, 1990
- mRNA phenotyping by enzymatic amplification of randomly primed cDNANucleic Acids Research, 1988
- Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA PolymeraseScience, 1988
- Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell AnemiaScience, 1985
- Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genomeNature, 1985
- Oral Poliovirus Vaccine: History of Its Development and Use and Current Challenge to Eliminate Poliomyelitis from the WorldThe Journal of Infectious Diseases, 1985
- Complete nucleotide sequences of all three poliovirus serotype genomesJournal of Molecular Biology, 1984
- The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1Nucleic Acids Research, 1983
- Present Position of Immunization Against Poliomyelitis with Live Virus VaccinesBMJ, 1959
- CHARACTERISTICS AND GENETIC POTENTIALITIES OF EXPERIMENTALLY PRODUCED AND NATURALLY OCCURRING VARIANTS OF POLIOMYELITIS VIRUSAnnals of the New York Academy of Sciences, 1955